R. Sanders  Williams net worth and biography

R. Williams Biography and Net Worth

Dr. R. Sanders Williams has served as a director of the Company since May 16, 2007. Dr. Williams serves currently as Senior Advisor for Science & Technology at Duke University and as President Emeritus of The J. David Gladstone Institutes, a non-profit biomedical research enterprise, holding both positions since January 1, 2018. Dr. Williams also currently is Professor of Medicine at the University of California San Francisco and Professor of Medicine at Duke University. Between February 1, 2021 and January 24, 2022 he fulfilled the role of Vice President (interim) for Research & Innovation at Duke University. Prior to these appointments he was president of The J. David Gladstone Institutes since November 2009, and he served as Chief Executive Officer of The J. David Gladstone Foundation, a non-profit organization supporting The J. David Gladstone Institutes, until December 31, 2018. Dr. Williams served Duke University between 2001 and 2010 as Dean of the School of Medicine, Senior Vice Chancellor, Senior Advisor for International Strategy, and founding Dean of the Duke-NUS Graduate Medical School Singapore. He has served previously as President of the Association of University Cardiologists, Chairman of the Research Committee of the American Heart Association, on the editorial boards of leading biomedical journals, on the Advisory Committee to the Director of the National Institutes of Health and on the board of external advisors of the National Heart, Lung and Blood Institute. Dr. Williams has served as a director of Tenaya Therapeutics, Inc. since October 2016 and has been a director of Amgen, Inc. since October 2014. Dr. Williams was a director of Bristol-Meyers Squibb Company from 2006 until 2013. Dr. Williams is a member of the National Academy of Medicine, and a Fellow of the American Association for the Advancement of Science.

What is R. Sanders Williams' net worth?

The estimated net worth of R. Sanders Williams is at least $1.16 million as of August 22nd, 2022. Dr. Williams owns 5,301 shares of Laboratory Co. of America stock worth more than $1,161,767 as of February 26th. This net worth estimate does not reflect any other assets that Dr. Williams may own. Learn More about R. Sanders Williams' net worth.

How do I contact R. Sanders Williams?

The corporate mailing address for Dr. Williams and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on R. Sanders Williams' contact information.

Has R. Sanders Williams been buying or selling shares of Laboratory Co. of America?

R. Sanders Williams has not been actively trading shares of Laboratory Co. of America during the past quarter. Most recently, R Sanders Williams sold 572 shares of the business's stock in a transaction on Friday, March 25th. The shares were sold at an average price of $272.98, for a transaction totalling $156,144.56. Learn More on R. Sanders Williams' trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, insiders at the medical research company sold shares 10 times. They sold a total of 51,793 shares worth more than $11,208,958.28. The most recent insider tranaction occured on February, 21st when CFO Glenn A Eisenberg sold 34,504 shares worth more than $7,451,828.88. Insiders at Laboratory Co. of America own 0.7% of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 2/21/2024.

R. Sanders Williams Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/25/2022Sell572$272.98$156,144.56View SEC Filing Icon  
7/8/2020Sell1,300$173.12$225,056.006,395View SEC Filing Icon  
8/5/2019Sell500$162.91$81,455.006,886View SEC Filing Icon  
5/6/2019Sell500$162.20$81,100.007,386View SEC Filing Icon  
2/13/2019Sell1,038$147.00$152,586.008,924View SEC Filing Icon  
11/27/2018Sell350$162.14$56,749.007,886View SEC Filing Icon  
8/11/2017Sell3,100$156.88$486,328.0010,073View SEC Filing Icon  
11/2/2015Sell1,850$124.30$229,955.004,176View SEC Filing Icon  
9/5/2014Sell2,000$107.95$215,900.00View SEC Filing Icon  
See Full Table

R. Sanders Williams Buying and Selling Activity at Laboratory Co. of America

This chart shows R Sanders Williams's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $219.16
Low: $216.55
High: $219.49

50 Day Range

MA: $223.81
Low: $215.65
High: $232.56

2 Week Range

Now: $219.16
Low: $174.20
High: $234.09

Volume

939,900 shs

Average Volume

710,941 shs

Market Capitalization

$18.61 billion

P/E Ratio

46.93

Dividend Yield

1.31%

Beta

1.04